Proposed OTC labeling changes would cost $155 mil. -- preliminary NDMA data.
This article was originally published in The Tan Sheet
PROPOSED OTC LABELING CHANGES WOULD COST INDUSTRY $155 MIL. if implemented over two years, according to preliminary data from an April survey of Nonprescription Drug Manufacturers Association members. Procter & Gamble Regulatory Affairs Section Head William Kozarek, PhD, told FDA at a May 8 OTC "feedback" meeting in Rockville, Md. that the agency's proposed labeling changes for branded and private label OTC products (excluding packaging), would cost industry $129 mil. and $26 mil., respectively, allowing for a two-year implementation period. FDA estimated in its Feb. 27 proposed OTC uniform labeling rule that the changes would cost $14.2 mil. ("The Tan Sheet" March 3, pp. 1-9).
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC